This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Cipla 2011 (Spanish version)
Deshpande, Rohit; Sucher, Sandra J.; Winig, LauraCase HBS-517S04Business Ethics and Corporate Social ResponsibilityDr. Yusuf Hamied, head of the Indian pharma and generics manufacturing company Cipla, is weighing options for how to continue to support the global fight against HIV/AIDS while positioning his company for growth in a changing regulatory landscape.Starting at €8.20
-
Cipla 2011
Deshpande, Rohit; Sucher, Sandra J.; Winig, LauraCase HBS-511050-EBusiness Ethics and Corporate Social ResponsibilityDr. Yusuf Hamied, head of the Indian pharma and generics manufacturing company Cipla, is weighing options for how to continue to support the global fight against HIV/AIDS while positioning his company for growth in a changing regulatory landscape.Starting at €8.20
-
Does Your Company's Conduct Meet World-Class Standards? (Spanish version)
Paine, Lynn Sharp; Deshpande, Rohit; Margolis, Joshua D.; Bettcher, Kim EricArticle HBS-R0512HBusiness Ethics and Corporate Social ResponsibilityCodes of conduct have long been a feature of corporate life. Today, they are arguably a legal necessity--at least for public companies with a presence in the United States. But the issue goes beyond U.S. legal and regulatory requirements. Sparked by corruption and excess of various types, dozens of industry, government, investor, and multisector groups worldwide have proposed codes and guidelines to govern corporate behavior. These initiatives re...Starting at €8.20
-
Serum Institute of India (SII) : Racing to Save Lives During a Pandemic
Deshpande, Rohit; Raina, Anjali; Chawla, RachnaCase HBS-521028-EBusiness Ethics and Corporate Social ResponsibilityThe CEO of Serum Institute of India (SII), a $12.8 billion Indian Family business is faced with a risky choice between principles and profit. SII is the largest manufacturer of vaccines in the world and Adar Poonawalla, the CEO and son of the founder has to decide how to temper his responsibility to meet the world's need for an affordable, efficacious and safe COVID-19 vaccine with his need to maintain profitability.Starting at €8.20